Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera

Krečak, Ivan; Skelin, Marko; Verstovsek, Srdan

doi:10.1080/17474086.2023.2199151

prikaz prve stranice dokumenta Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera

No public access

Scientific paper - Original scientific paper

Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera

Expert Review of Hematology, 16 (2023), 5; 305-316. https://doi.org/10.1080/17474086.2023.2199151

Krečak, Ivan; Skelin, Marko; Verstovsek, Srdan

Request a copy
of the document

Cite this document

APA 6th Edition

Krečak, I., Skelin, M. & Verstovsek, S. (2023). Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera. Expert Review of Hematology, 16. (5), 305-316. doi: 10.1080/17474086.2023.2199151

MLA 8th Edition

Krečak, Ivan, et al. "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera." Expert Review of Hematology, vol. 16, no. 5, 2023, pp. 305-316. https://doi.org/10.1080/17474086.2023.2199151

Chicago 17th Edition

Krečak, Ivan, Marko Skelin and Srdan Verstovsek. "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera." Expert Review of Hematology 16, no. 5 (2023): 305-316. https://doi.org/10.1080/17474086.2023.2199151

Harvard

Krečak, I., Skelin, M. and Verstovsek, S. (2023) 'Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera', Expert Review of Hematology, 16(5), pp. 305-316. doi: 10.1080/17474086.2023.2199151

Vancouver

Krečak I, Skelin M, Verstovsek S. Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera. Expert Review of Hematology [Internet]. 2023 April 05 [cited 2024 December 03];16(5):305-316. doi: 10.1080/17474086.2023.2199151

IEEE

I. Krečak, M. Skelin and S. Verstovsek, "Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera", Expert Review of Hematology, vol. 16, no. 5, pp. 305-316, April 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:671197. [Accessed: 03 December 2024]

Cite this item: https://urn.nsk.hr/urn:nbn:hr:184:671197

Please login to the repository to save this object to your list.

Metadata

Title (english)	Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera
Author	Ivan Krečak
Author	Marko Skelin
Author	Srdan Verstovsek
Author's institution	University of Rijeka Faculty of Medicine (Department of Internal Medicine)
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Internal Medicine
Keywords (english)
Language	english
Publication type	Scientific paper - Original scientific paper
Publication status	Published
Peer review	Peer review - international
Publication version	Published version
Journal title	Expert Review of Hematology
Numbering	vol. 16, no. 5, pp. 305-316
p-ISSN	1747-4086
e-ISSN	1747-4094
DOI	https://doi.org/10.1080/17474086.2023.2199151
URN:NBN	urn:nbn:hr:184:671197
Publication	2023-04-05
Document URL	https://www.tandfonline.com/doi/full/10.1080/17474086.2023.2199151
Type of resource	Text
Access conditions	Closed access
Terms of use
Created on	2023-08-21 11:58:19